RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

The third stock on our list of the best gene-editing stocks to buy is Moderna, Inc. (NASDAQ:MRNA). It is a biotechnology company focused on developing mRNA-based therapeutics and vaccines for a ...

A Nature analysis reveals the 25 highest-cited papers published this century and explores why they are breaking records.

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Lee said there is massive potential for mRNA-based therapeutics for neurological and other conditions. While the creation of gene-editing therapeutics has quickly advanced, delivery systems for ...

ToolGen, Inc. (KOSDAQ 199800), led by CEO Jong Sang Ryu and recognized as a global leader in genome editing technology, announced today that it has filed a patent infringement lawsuit in the United ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...